70 related articles for article (PubMed ID: 21623559)
1. Low dose endoluminal photodynamic therapy improves murine T cell-mediated colitis.
Favre L; Borle F; Velin D; Bachmann D; Bouzourene H; Wagnieres G; van den Bergh H; Ballabeni P; Gabrecht T; Michetti P; Schreiber S; Ortner MA
Endoscopy; 2011 Jul; 43(7):604-16. PubMed ID: 21623559
[TBL] [Abstract][Full Text] [Related]
2. Ameliorating effect of saporin-conjugated anti-CD11b monoclonal antibody in a murine T-cell-mediated chronic colitis.
Kanai T; Uraushihara K; Totsuka T; Nemoto Y; Fujii R; Kawamura T; Makita S; Sawada D; Yagita H; Okumura K; Watanabe M
J Gastroenterol Hepatol; 2006 Jul; 21(7):1136-42. PubMed ID: 16824065
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice.
Elson CO; Cong Y; Weaver CT; Schoeb TR; McClanahan TK; Fick RB; Kastelein RA
Gastroenterology; 2007 Jun; 132(7):2359-70. PubMed ID: 17570211
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potency of IL2-caspase 3 targeted treatment in a murine experimental model of inflammatory bowel disease.
Shteingart S; Rapoport M; Grodzovski I; Sabag O; Lichtenstein M; Eavri R; Lorberboum-Galski H
Gut; 2009 Jun; 58(6):790-8. PubMed ID: 18978179
[TBL] [Abstract][Full Text] [Related]
5. Role of interleukin-12 in the induction of mucosal inflammation and abrogation of regulatory T cell function in chronic experimental colitis.
Liu Z; Geboes K; Heremans H; Overbergh L; Mathieu C; Rutgeerts P; Ceuppens JL
Eur J Immunol; 2001 May; 31(5):1550-60. PubMed ID: 11465113
[TBL] [Abstract][Full Text] [Related]
6. Pivotal roles of interleukin-6 in transmural inflammation in murine T cell transfer colitis.
Kitamura K; Nakamoto Y; Kaneko S; Mukaida N
J Leukoc Biol; 2004 Dec; 76(6):1111-7. PubMed ID: 15339938
[TBL] [Abstract][Full Text] [Related]
7. Ameliorating effect of anti-inducible costimulator monoclonal antibody in a murine model of chronic colitis.
Totsuka T; Kanai T; Iiyama R; Uraushihara K; Yamazaki M; Okamoto R; Hibi T; Tezuka K; Azuma M; Akiba H; Yagita H; Okumura K; Watanabe M
Gastroenterology; 2003 Feb; 124(2):410-21. PubMed ID: 12557147
[TBL] [Abstract][Full Text] [Related]
8. Analysis of cytokine production in the colon of nude mice with experimental colitis induced by adoptive transfer of immunocompetent cells from mice infected with a murine retrovirus.
Suriki H; Suzuki K; Baba Y; Hasegawa K; Narisawa R; Okada Y; Mizuochi T; Kawachi H; Shimizu F; Asakura H
Clin Immunol; 2000 Oct; 97(1):33-42. PubMed ID: 10998315
[TBL] [Abstract][Full Text] [Related]
9. Colon lamina propria dendritic cells induce a proinflammatory cytokine response in lamina propria T cells in the SCID mouse model of colitis.
Drakes ML; Blanchard TG; Czinn SJ
J Leukoc Biol; 2005 Dec; 78(6):1291-300. PubMed ID: 16204624
[TBL] [Abstract][Full Text] [Related]
10. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses.
González MA; Gonzalez-Rey E; Rico L; Büscher D; Delgado M
Gastroenterology; 2009 Mar; 136(3):978-89. PubMed ID: 19135996
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow retaining colitogenic CD4+ T cells may be a pathogenic reservoir for chronic colitis.
Nemoto Y; Kanai T; Makita S; Okamoto R; Totsuka T; Takeda K; Watanabe M
Gastroenterology; 2007 Jan; 132(1):176-89. PubMed ID: 17241870
[TBL] [Abstract][Full Text] [Related]
12. The interleukin-1 beta-converting enzyme inhibitor pralnacasan reduces dextran sulfate sodium-induced murine colitis and T helper 1 T-cell activation.
Loher F; Bauer C; Landauer N; Schmall K; Siegmund B; Lehr HA; Dauer M; Schoenharting M; Endres S; Eigler A
J Pharmacol Exp Ther; 2004 Feb; 308(2):583-90. PubMed ID: 14610233
[TBL] [Abstract][Full Text] [Related]
13. Amelioration of experimental colitis by Copaxone is associated with class-II-restricted CD4 immune blocking.
Gur C; Karussis D; Golden E; Doron S; Ilan Y; Safadi R
Clin Immunol; 2006; 118(2-3):307-16. PubMed ID: 16290121
[TBL] [Abstract][Full Text] [Related]
14. Colitis-related public T cells are selected in the colonic lamina propria of IL-10-deficient mice.
Takahashi I; Matsuda J; Gapin L; DeWinter H; Kai Y; Tamagawa H; Kronenberg M; Kiyono H
Clin Immunol; 2002 Mar; 102(3):237-48. PubMed ID: 11890710
[TBL] [Abstract][Full Text] [Related]
15. Experimental inflammatory bowel disease--role of T cells.
Szczepanik M; Gryglewski A; Bryniarski K; Stachura J; Ptak W
J Physiol Pharmacol; 2000 Jun; 51(2):333-46. PubMed ID: 10898104
[TBL] [Abstract][Full Text] [Related]
16. CD8+ cytotoxic T cells induce relapsing colitis in normal mice.
Nancey S; Holvöet S; Graber I; Joubert G; Philippe D; Martin S; Nicolas JF; Desreumaux P; Flourié B; Kaiserlian D
Gastroenterology; 2006 Aug; 131(2):485-96. PubMed ID: 16890603
[TBL] [Abstract][Full Text] [Related]
17. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile.
Daniel C; Sartory NA; Zahn N; Radeke HH; Stein JM
J Pharmacol Exp Ther; 2008 Jan; 324(1):23-33. PubMed ID: 17911375
[TBL] [Abstract][Full Text] [Related]
18. Influence of intestinal bacteria on induction of regulatory T cells: lessons from a transfer model of colitis.
Strauch UG; Obermeier F; Grunwald N; Gürster S; Dunger N; Schultz M; Griese DP; Mähler M; Schölmerich J; Rath HC
Gut; 2005 Nov; 54(11):1546-52. PubMed ID: 15987795
[TBL] [Abstract][Full Text] [Related]
19. Prevention of colitis by interleukin 10-transduced T lymphocytes in the SCID mice transfer model.
Van Montfrans C; Rodriguez Pena MS; Pronk I; Ten Kate FJ; Te Velde AA; Van Deventer SJ
Gastroenterology; 2002 Dec; 123(6):1865-76. PubMed ID: 12454844
[TBL] [Abstract][Full Text] [Related]
20. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease.
Lee J; Lee EN; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Lee KW; Kwon GY; Joh JW; Kim SJ
Immunol Lett; 2005 Nov; 101(2):210-6. PubMed ID: 16026855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
